Antibody Drugs

Antibody Drugs includes companies developing monoclonal antibodies or related antibody-based therapeutics. These assets are central to many oncology, immunology, and rare-disease franchises because they can offer target specificity and scalable biologic development paths.

Why watch Antibody Drugs

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Antibody Drugs news

The latest feed items from companies currently grouped under Antibody Drugs.

1. 01
   2026-08-06 20:01 EST

   CRVSCorvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results

   Source: Corvus Pharmaceuticals

2. 02
   2026-08-06 11:48 EST

   ARGXargenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.

   Source: Argenx

3. 03
   2026-08-06 11:30 EST

   IFRXInflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

   Source: Inflarx NV

4. 04
   2026-08-06 11:30 EST

   CMPXCompass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update

   Source: Compass Therapeutics

5. 05
   2026-08-03 20:01 EST

   ARGXargenx announces Extraordinary General Meeting of Shareholders on September 17, 2026

   Source: Argenx

6. 06
   2026-07-31 11:00 EST

   REGNRegeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation

   Source: Regeneron Pharmaceuticals

7. 07
   2026-07-30 20:01 EST

   CRVSCorvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026

   Source: Corvus Pharmaceuticals

8. 08
   2026-07-30 11:30 EST

   IFRXInflaRx to Report Second Quarter 2026 Results on August 6, 2026

   Source: Inflarx NV

9. 09
   2026-07-30 10:30 EST

   REGNRegeneron Reports Second Quarter 2026 Financial and Operating Results

   Source: Regeneron Pharmaceuticals

10. 10
    2026-07-29 09:08 EST

    GSKCabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026

    Source: GSK plc

11. 11
    2026-07-28 12:05 EST

    GSKGSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK

    Source: GSK plc

12. 12
    2026-07-28 12:00 EST

    LEGNLegend Biotech to Host Investor Conference Call on Second Quarter 2026 Results

    Source: Legend Biotech Corporation

13. 13
    2026-07-28 12:00 EST

    GSKGSK delivers strong Q2 core results performance and continued momentum. Plans announced to accelerate R&D and late-stage pipeline portfolio. Expect 20+ phase III trial starts in 2026

    Source: GSK plc

14. 14
    2026-07-28 11:00 EST

    GSKGSK’s licensor Hansoh Pharma announces positive results from a second phase III trial for Ris-Rez in China

    Source: GSK plc

15. 15
    2026-07-27 14:55 EST

    GSKViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV

    Source: GSK plc

16. 16
    2026-07-27 10:00 EST

    LEGNLegend Biotech Announces CEO Transition

    Source: Legend Biotech Corporation

17. 17
    2026-07-27 05:00 EST

    ARGXargenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline

    Source: Argenx

18. 18
    2026-07-23 05:00 EST

    ARGXargenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update

    Source: Argenx

19. 19
    2026-07-22 11:21 EST

    GSKJideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer

    Source: GSK plc

20. 20
    2026-07-21 10:28 EST

    GSKViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026

    Source: GSK plc

Companies in Antibody Drugs

15 companies tagged with Antibody Drugs.

Frequently Asked Questions